Anzeige
Mehr »
Login
Mittwoch, 25.05.2022 Börsentäglich über 12.000 News von 666 internationalen Medien
InnoCan Pharma: Den Masterkey für "Big Pharma" im Patent-Portfolio?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P2F1 ISIN: GB00BMDY1P48 Ticker-Symbol:  
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
LOVE HEMP GROUP PLC Chart 1 Jahr
5-Tage-Chart
LOVE HEMP GROUP PLC 5-Tage-Chart
ACCESSWIRE
252 Leser
Artikel bewerten:
(1)

Love Hemp Group PLC Announces Update to Announcement of 9 May 2022

LONDON, UK / ACCESSWIRE / May 13, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focused on CBD health and wellness solutions, provides a further update at the request of Peterhouse Capital Limited ("Peterhouse").

The announcement released by Love Hemp on 9 May 2022 incorrectly stated that Peterhouse Capital Limited ("Peterhouse") had resigned as the Company's AQSE Corporate Adviser "following the update by the Company that an investor in the February 2022 placing had failed to complete their investment of £1.2 million."

Love Hemp wishes to clarify that Peterhouse in fact resigned as the Company's AQSE Corporate Adviser before the release of the Company's update on 3 May 2022 and that the investor who failed to complete their investment of £1.2 million was a participant in the subscription, not the placing by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please visit: www.lovehempgroup.com or contact:

Love Hemp Group

Andrew Male
Chairman & Director

+44 (0) 7926 397 675

andrew.male@lovehempgroup.com

Financial Advisor

Rupert Fane

H&P Advisory Limited

+44 (0) 20 7907 8500

rf@hannam.partners

Financial PR

Tim Blythe/Alice McLaren/Madeleine Gordon-Foxwell

BlytheRay

+44 (0) 207 138 3204

lovehemp@blytheray.com

About Love Hemp Group

Love Hemp Group is a brand-led consumer goods company focused on health and wellness solutions for consumer use cases including sleep, pain, anxiety, stress and recovery. The Company is a pioneer in the UK-based premium high-quality CBD market, with over 40 products including oils, edibles, sprays, cosmetics and topicals. The Company's range of products are sold online across 70 websites and in over 2,000 stores including some of the biggest retailers in the UK, such as Holland & Barrett, Boots and Ocado. Listed on the Aquis Stock Exchange (AQSE: LIFE) the Company recently changed its name to Love Hemp Group plc, from World High Life, to better reflect its focus on supporting the "best in class" CBD brand as it embarks on a wider expansion of its core business and offering.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Love Hemp Group PLC



View source version on accesswire.com:
https://www.accesswire.com/701301/Love-Hemp-Group-PLC-Announces-Update-to-Announcement-of-9-May-2022

LOVE HEMP GROUP-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2022 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.